Stock Events

Stock Events

Halozyme Therapeutics (HALO) Q3 2020 Earnings

10AugConfirmed

Q4 2019

Q1 2020

Q2 2020

Q3 2020

-0.24

-0.07

0.1

0.27

Details

Expected EPS

0.27

Actual EPS

0.19

Surprise EPS

-0.08

Surprise Percent

+29.63%

Description

Halozyme Therapeutics (HALO) has reported earnings of 0.19 per share for Q3 2020.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.